These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 26569104)

  • 1. Autologous Plasma Rich in Growth Factors Eyedrops in Refractory Cases of Ocular Surface Disorders.
    Merayo-Lloves J; Sanchez RM; Riestra AC; Anitua E; Begoña L; Orive G; Fernandez-Vega L
    Ophthalmic Res; 2015; 55(2):53-61. PubMed ID: 26569104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of patients with neurotrophic keratitis stages 2 and 3 with plasma rich in growth factors (PRGF-Endoret) eye-drops.
    Sanchez-Avila RM; Merayo-Lloves J; Riestra AC; Fernandez-Vega Cueto L; Anitua E; Begoña L; Muruzabal F; Orive G
    Int Ophthalmol; 2018 Jun; 38(3):1193-1204. PubMed ID: 28620707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and Efficacy of Autologous Plasma Rich in Growth Factors Eye Drops for the Treatment of Evaporative Dry Eye.
    Merayo-Lloves J; Sanchez-Avila RM; Riestra AC; Anitua E; Begoña L; Orive G; Fernandez-Vega L
    Ophthalmic Res; 2016 Jul; 56(2):68-73. PubMed ID: 27229893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effect of Immunologically Safe Plasma Rich in Growth Factor Eye Drops in Patients with Sjögren Syndrome.
    Sanchez-Avila RM; Merayo-Lloves J; Riestra AC; Anitua E; Muruzabal F; Orive G; Fernández-Vega L
    J Ocul Pharmacol Ther; 2017 Jun; 33(5):391-399. PubMed ID: 28375790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma Rich in Growth Factors for the Treatment of Dry Eye after LASIK Surgery.
    Sanchez-Avila RM; Merayo-Lloves J; Fernandez ML; Rodriguez-Gutierrez LA; Jurado N; Muruzabal F; Orive G; Anitua E
    Ophthalmic Res; 2018; 60(2):80-86. PubMed ID: 29886478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma rich in growth factors eye drops to treat secondary ocular surface disorders in patients with glaucoma.
    Sánchez-Avila RM; Merayo-Lloves J; Fernández ML; Rodríguez-Gutiérrez LA; Rodríguez-Calvo PP; Fernández-Vega Cueto A; Muruzabal F; Orive G; Anitua E
    Int Med Case Rep J; 2018; 11():97-103. PubMed ID: 29760570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PRGF exerts more potent proliferative and anti-inflammatory effects than autologous serum on a cell culture inflammatory model.
    Anitua E; Muruzabal F; de la Fuente M; Riestra A; Merayo-Lloves J; Orive G
    Exp Eye Res; 2016 Oct; 151():115-21. PubMed ID: 27567559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma rich in growth factors as a therapeutic agent for persistent corneal epithelial defects.
    López-Plandolit S; Morales MC; Freire V; Etxebarría J; Durán JA
    Cornea; 2010 Aug; 29(8):843-8. PubMed ID: 20508516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma rich in growth factors for the treatment of dry eye from patients with graft versus host diseases.
    Sanchez-Avila RM; Merayo-Lloves J; Muruzabal F; Orive G; Anitua E
    Eur J Ophthalmol; 2020 Jan; 30(1):94-103. PubMed ID: 30585084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of plasma rich in growth factors for the treatment of dry eye.
    López-Plandolit S; Morales MC; Freire V; Grau AE; Durán JA
    Cornea; 2011 Dec; 30(12):1312-7. PubMed ID: 22012030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicenter report of the use of plasma rich in growth factors (PRGF) for the treatment of patients with ocular surface diseases in North America.
    Soifer M; Tovar A; Wang M; Mousa HM; Yennam S; Sabater AL; Pflugfelder SC; Perez VL
    Ocul Surf; 2022 Jul; 25():40-48. PubMed ID: 35489588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Plasma Rich in Growth Factors (PRGF) Eye Drops on Ocular Redness and Symptomatology in Patients with Dry Eye Disease.
    Lozano-Sanroma J; Barros A; Alcalde I; Sánchez-Ávila RM; Queiruga-Piñeiro J; Fernández-Vega Cueto L; Merayo-Lloves J
    Medicina (Kaunas); 2023 May; 59(5):. PubMed ID: 37241160
    [No Abstract]   [Full Text] [Related]  

  • 13. Autologous serum eyedrops in the treatment of aniridic keratopathy.
    López-García JS; Rivas L; García-Lozano I; Murube J
    Ophthalmology; 2008 Feb; 115(2):262-7. PubMed ID: 17675158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma rich in growth factors (PRGF) eye drops stimulates scarless regeneration compared to autologous serum in the ocular surface stromal fibroblasts.
    Anitua E; de la Fuente M; Muruzabal F; Riestra A; Merayo-Lloves J; Orive G
    Exp Eye Res; 2015 Jun; 135():118-26. PubMed ID: 25708868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmapheresis, Intravenous Immunoglobulins, and Autologous Serum Eyedrops in the Acute Eye Complications of Toxic Epidermal Necrolysis.
    Pinna A; Nuvoli E; Blasetti F; Posadinu MA; Boscia F
    Eur J Ophthalmol; 2017 Nov; 27(6):658-663. PubMed ID: 28362052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma rich in growth factors membrane as coadjuvant treatment in the surgery of ocular surface disorders.
    Sanchez-Avila RM; Merayo-Lloves J; Riestra AC; Berisa S; Lisa C; Sánchez JA; Muruzabal F; Orive G; Anitua E
    Medicine (Baltimore); 2018 Apr; 97(17):e0242. PubMed ID: 29702971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined therapy of ocular surface disease with plasma rich in growth factors and scleral contact lenses.
    Wang M; Yennam S; McMillin J; Chen HH; de la Sen-Corcuera B; Hemmati R; Pflugfelder S
    Ocul Surf; 2022 Jan; 23():162-168. PubMed ID: 34537416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The use of autologous serum in the treatment of the ocular surface diseases].
    Wilczyński M
    Klin Oczna; 2009; 111(10-12):363-8. PubMed ID: 20169898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of Autologous Serum Tears for the Treatment of Ocular Surface Disease From Patients With Systemic Autoimmune Diseases.
    Ali TK; Gibbons A; Cartes C; Zarei-Ghanavati S; Gomaa M; Gonzalez I; Gonzalez AE; Ozturk HE; Betancurt C; Perez VL
    Am J Ophthalmol; 2018 May; 189():65-70. PubMed ID: 29470971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized double-blind clinical trial of autologous serum versus artificial tears in dry eye syndrome.
    Urzua CA; Vasquez DH; Huidobro A; Hernandez H; Alfaro J
    Curr Eye Res; 2012 Aug; 37(8):684-8. PubMed ID: 22670856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.